SIX1驱动临床前肺动脉高压内皮功能障碍
在PAH和IPF相关PH患者肺血管内皮中SIX1表达升高,沉默SIX1可抑制缺氧诱导的内皮功能障碍;内皮特异性敲除Six1改善SuHx小鼠PH,过表达诱导野生型小鼠自发PH;zafirlukast抑制SIX1转录活性并逆转SuHx大鼠PH,机制涉及SIX1调控MAST4转录及MAPK1/3活化。
要点
- SIX1在PAH和IPF相关PH患者肺血管内皮中表达升高。
- 内皮特异性敲除Six1改善SuHx小鼠PH,过表达诱导野生型小鼠自发PH。
- Zafirlukast抑制SIX1转录活性并逆转SuHx大鼠PH。
核心结论
- SIX1通过调控MAST4转录及后续MAPK1/3活化驱动内皮功能障碍和PH,靶向SIX1可能是PAH治疗和药物开发的有前景策略。
研究设计与样本
- 研究检测PAH和IPF相关PH患者肺血管内皮中SIX1表达,并在体外缺氧诱导内皮功能障碍模型及SuHx诱导PH小鼠和Sprague-Dawley大鼠中开展干预实验。
- 采用内皮特异性Six1敲除和腺相关病毒介导的过表达小鼠模型,结合结构虚拟筛选和表面等离子共振分析鉴定SIX1抑制剂。
- 对体外缺氧诱导内皮功能障碍进行多组学分析以探索SIX1下游靶点。
主要发现
- PAH和IPF相关PH患者肺血管内皮中SIX1升高。
- siRNA沉默SIX1抑制缺氧诱导的内皮细胞增殖、内皮-间质转化和内皮素-1释放。
- 内皮特异性Six1敲除改善SuHx小鼠肺血流动力学、内皮功能障碍、肺动脉重塑和右心室功能。
- 腺相关病毒介导的内皮特异性Six1过表达诱导野生型C57BL/6小鼠自发PH。
- Zafirlukast抑制缺氧诱导的内皮功能障碍并逆转SuHx诱导的Sprague-Dawley大鼠PH。
临床怎么用
- SIX1可作为PAH内皮功能障碍的潜在治疗靶点,zafirlukast作为SIX1转录活性抑制剂值得进一步临床转化研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endothelial dysfunction plays a critical role in the initiation and progression of vascular remodeling and pulmonary arterial hypertension (PAH). Sine oculis homeobox 1 (SIX1) is a developmentally restricted transcription factor, and its expression ceases upon the completion of embryonic development. Deletion of Six1 impairs the differentiation of pulmonary vascular endothelial cells, resulting in pulmonary vascular defects and postnatal death. In this study, we found that SIX1 was increased in the endothelia of pulmonary arteries from patients with PAH and from patients with idiopathic pulmonary fibrosis-associated pulmonary hypertension (PH). Silencing SIX1 using siRNA inhibited hypoxia-induced endothelial dysfunction in vitro, including proliferation, endothelial-to-mesenchymal transition, and endothelin-1 release. Endothelial-specific Six1 knockout improved pulmonary hemodynamics, endothelial dysfunction, pulmonary artery remodeling, and right ventricular function in SU5416/hypoxia (SuHx)-induced PH mice. Moreover, endothelial-specific Six1 overexpression mediated by adeno-associated virus induced a spontaneous PH in wild-type C57BL/6 mice. Structure-based virtual screening and surface plasmon resonance analysis demonstrated that zafirlukast was an inhibitor of SIX1 transcriptional activity. Zafirlukast suppressed hypoxia-induced endothelial dysfunction in vitro and reversed SuHx-induced PH in Sprague-Dawley rats. Mechanistically, multiomics profiling of hypoxia-induced endothelial dysfunction in vitro revealed that microtubule-associated serine/threonine kinase family member 4 (MAST4) was a target of SIX1. MAST4 phosphorylated the Thr185/202 sites of mitogen-activated protein kinases 1 and 3 (MAPK1/3), resulting in endothelial dysfunction. Overall, we found that SIX1 was a driver for endothelial dysfunction and PH through regulating MAST4 transcription and subsequently MAPK1/3 activation. Targeting SIX1 may be a promising strategy for PAH treatment and drug development.
引用
- Liu T, Zhou W, Fang C, et al. Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension. Sci Transl Med. 2026. PMID: 41637526. doi:10.1126/scitranslmed.adu6425
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。